News

27.03.2019

From laboratory to your medicine: EMA’s new booklet explains it all

Have you ever wondered how a new medicine is approved for the treatment of your disease?  We have the answer….

EU collaboration in health for better access: Taking stock and looking to the future

27.03.2019

The Patient Access Partnership (PACT) gathered a wide range of stakeholders at the MEP Interest Group on Access to Healthcare…

Joint effort for equitable access to employment

27.03.2019

The Brain, Mind & Pain MEP Interest Group, hosted by MEP Jeroen Leaners, held its last meeting during this parliamentary…

08.03.2019

Event report: “Lifting the Burden of Neurological Disorders in Europe” panel discussion in the European Parliament

The European Federation of Neurological Associations (EFNA) and the European Academy of Neurology (EAN) jointly organized an event entitled “Lifting…

21st State of Art Symposium around the challenges of MS treatment in Switzerland

08.03.2019

Paediatric MS and MS in old age were the two main topics neurologists explored at the 21st State of the…

Danish MS Society offers Trauma Releasing Exercises (TRE) training for MS patients

08.03.2019

TRE (tension and trauma releasing exercises) is a therapeutic method for relieving trauma and stress. The method was developed by…

08.03.2019

After 20 years, the “Is MS Treatment Still a Lottery?” campaign has achieved its objective in Croatia

The Croatian MS Society presented new guidelines for Multiple Sclerosis (MS) treatment which, after 20 years, will finally provide timely…

More than 21,000 people call for action on ocrelizumab for Primary Progressive MS in the UK

08.03.2019

More than 21,000 people have signed a petition launched by the MS Society UK, calling for ocrelizumab to be made…

Oceans of Hope: sailing with MS in 2019

08.03.2019

We have previously featured the Oceans of Hope (OoH) yacht that circumnavigated the world in 2014. There were approximately 100…

1 21 22 23 24 25 69